Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.420
-0.430 (-11.17%)
At close: Mar 3, 2025, 4:00 PM
3.430
+0.010 (0.29%)
After-hours: Mar 3, 2025, 5:36 PM EST
Absci Employees
Absci had 155 employees as of December 31, 2023. The number of employees decreased by 38 or -19.69% compared to the previous year.
Employees
155
Change (1Y)
-38
Growth (1Y)
-19.69%
Revenue / Employee
$27,142
Profits / Employee
-$630,116
Market Cap
392.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 155 | -38 | -19.69% |
| Dec 31, 2022 | 193 | -19 | -8.96% |
| Dec 31, 2021 | 212 | 110 | 107.84% |
| Dec 31, 2020 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ABSI News
- 13 days ago - Absci to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Benzinga
- 5 weeks ago - Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 7 weeks ago - Absci Looks Cheap And Positioned For Growth With AMD's AI Backing - Seeking Alpha
- 7 weeks ago - Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery - GlobeNewsWire
- 7 weeks ago - Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery - GlobeNewsWire
- 2 months ago - Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health - GlobeNewsWire
- 3 months ago - Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript - Seeking Alpha